Tomonori Yaguchi

10PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer cell biologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 24, 2026
Tumor-Derived Extracellular Vesicles in Plasma for Predicting Anti-PD-1 Antibody Efficacy in Non-Small Cell Lung Cancer.

|Apr 20, 2026
Multifunctional Role of Mitochondrial Fatty Acid Oxidation in Cancer Immunotherapy and Aging.

|Feb 17, 2026
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer.

Katsuhiro Ito, Kei Iida, Tomoko Hirano

|Dec 05, 2025
Chimeric MHC class I- and II-restricted non-self epitopes broaden antitumor T cell reactions.

Rongsheng Zhang, Rong Ma, Merrin M L Leong

|Dec 02, 2025
Age-related immune states and PD-1 blockade: mechanisms and strategies for the elderly.

Tomonori Yaguchi, Kenji Chamoto, Tasuku Honjo

|Jan 22, 2025
Beneficial effects on T cells by photodynamic therapy with talaporfin enhance cancer immunotherapy.

Ehab M Ezzaldeen, Tomonori Yaguchi, Ryotaro Imagawa

Pageof 2

Frequent Collaborators

3 joint publications

Kenji Chamoto

3 joint publications

Yutaka Kawakami

2 joint publications

Kei Iida

2 joint publications

Merrin Man Long Leong